8,343,503 for composition of matter and medical use for AllerT, which treats birch pollen allergies

composition-of-matter patents for a family of peptides being developed for the treatment of neurological and neurodegenerative diseases

It covers compositions of matter and methods of producing and formulating anthrax vaccines

8,226,975, a composition-of-matter patent for Arikace (liposomal. amikacin for inhalation), a treatment and prophylaxis for pulmonary infections

8,178,518 for composition of matter concerning Testim 1% testosterone gel

8,148,526, covering composition-of-matter claims for ACY-1215, its HDAC6 inhibitor candidate in clinical trials for multiple myeloma

Lorus Therapeutics Inc., of Toronto, received a patent for lead small-molecule cancer drug LOR-253, covering composition of matter and methods of treating cancer

It provides composition-of-matter protection for investigational pan-Bcr-Abl inhibitor ponatinib

8,101,396, which encompasses compositions of matter related to the antibody-based targeted delivery of biologically active compounds using the firm's minicell-delivery platform technology

8,053,440, which contains composition-of-matter claims for lead molecule RVX-208 and structurally related compounds

It covers the composition of matter for selected 8-hydroxy quinazolinone compounds, including lead Parkinson's disease candidate PBT434

Critical Outcome Technologies Inc., of London, Ontario, received a composition-of-matter patent for its lead oncology candidate COTI-2

8,025,877, and 8,026,342, which claim methods and composition of matter for its anti-sphingosine-1-phosphate antibody, sonepcizumab, the active component in the firm's lead compounds iSONEP and ASONEP

Allon Therapeutics Inc., of Vancouver, British Columbia, was granted a patent covering the compositions of matter for the D-isomer of NAP (davunetide), which is known as AL-408 in the firm's pipeline

It relates to the composition of matter of PSI-7977 and its diastereomeric mixture for treating hepatitis C virus

7,956,173, which covers composition of matter related to sonepcizumab, the drug substance in the firm's lead compounds, iSONEP and ASONEP

7,943,762, titled "Oligonucleotide Analogs Having Cationic Intersubunit Linkages," which covers composition of matter for its advanced generation of phosphorodiamidate morpholino oligonucleotide chemistry called PMOplus

7,838,006, titled "Viral vaccine composition, process and methods of use," relating to claims covering the composition of matter for Immunitor's lead product, V5

7,842,820 titled "Novel sulfonylpyrroles" relating to the composition of matter and pharmaceutical compositions of a group of compounds, including resminostat